Viking Therapeutics, Inc. VKTX
NASDAQ · United States · Health Technology
$32.60+0.79 (+2.48%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-29 | -1.10 | -1.23 | +10.8% | $0 | — | -2.2%$33.86→$33.11 |
| Q1 2026 | 2026-04-29 | -1.37 | -0.91 | -50.5% | — | — | -3.7%$32.39→$31.18 |
| Q4 2025 | 2026-02-11 | -1.38 | -0.90 | -53.3% | — | — | +6.1%$28.75→$30.49 |
| Q3 2025 | 2025-10-22 | -0.81 | -0.67 | -20.9% | — | — | +2.9%$32.98→$33.92 |
| Q2 2025 | 2025-07-23 | -0.58 | -0.44 | -31.8% | — | — | — |
| Q1 2025 | 2025-04-23 | -0.41 | -0.31 | -32.3% | — | — | — |
| Q4 2024 | 2025-02-05 | -0.32 | -0.27 | -18.5% | — | — | — |
| Q3 2024 | 2024-10-23 | -0.22 | -0.24 | +8.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.